Inflexion invests in Medivet

The fresh capital will enable Medivet to continue pursuing its acquisitive growth strategy, which has seen it establish a chain of 160 practices across the UK.

As part of the deal, Inflexion partner Mark Williams will take a seat on the Medivet board of directors.

Financial details of the transaction remain undisclosed, though capital for the transaction was drawn from Inflexion’s 2014-vintage £400m Partnership Capital Fund I, which provides equity tickets in the £15-75m range. The fund recently invested £41m in UK financial consultancy Lane Clark & Peacock.

Vet care has emerged as an attractive space for private equity investors, leading to increasingly large and high profile buyouts, as unquote" found in its recent in-depth analysis of the veterinary sector.

Company
Founded in 1986 and headquartered in Watford, Medivet is a veterinary clinic operator with 160 practices. According to publicly available records, the business generated a turnover of £67m in the year ending April 2016, with EBITDA of £12m.

People
Inflexion Private Equity – David Whileman (head of partnership capital); Mark Williams (partner); Andrew Neville (assistant director); Chloe Holding (investment executive).
Medivet – Arnold Levy (CEO).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• UK / Ireland
• Healthcare
• Expansion
• United Kingdom
• Inflexion Private Equity